Acoustic neuroma is most definitively diagnosed with an MRI scan using contrast dye, which can detect tumors as small as 1 to 2 millimeters. But the path to that MRI typically starts with recognizing a pattern of symptoms, followed by hearing tests that raise enough suspicion to justify imaging. Here’s what that diagnostic process looks like from start to finish.
Symptoms That Trigger the Workup
The vast majority of acoustic neuromas (also called vestibular schwannomas) announce themselves through hearing changes in one ear. In a study of 945 people with these tumors, unilateral hearing loss was the first symptom in 80% of cases. The loss tends to be gradual and affects higher-pitched sounds more than lower ones, though in rare cases it can come on suddenly.
Tinnitus, a ringing or buzzing in one ear, is the next most common initial complaint, showing up as the primary symptom in about 6% of cases. Notably, around 10% of people with acoustic neuromas seek help for one-sided tinnitus without noticing any hearing loss at all. Unilateral tinnitus alone is considered sufficient reason to evaluate for a tumor.
Balance problems are less common as a first symptom, appearing in fewer than 10% of patients at initial presentation. That said, when patients are asked directly, 40 to 50% report some degree of unsteadiness or imbalance. Vertigo, headache, and coordination difficulties (ataxia) each account for a small percentage of initial complaints, at roughly 3 to 4% each.
Hearing Tests as a Screening Step
A standard hearing test (audiogram) is usually the first diagnostic step. The audiologist measures how well each ear detects sounds at different frequencies and how clearly you understand spoken words. What they’re looking for is asymmetry between the two ears, since acoustic neuromas almost always affect one side.
Professional guidelines use specific thresholds to flag results as suspicious. The American Academy of Otolaryngology considers an average difference of 15 decibels or more between ears across several mid-range frequencies to be a red flag. A difference of more than 15% in word recognition scores between ears also warrants further investigation. These criteria exist because not every case of uneven hearing points to a tumor, but asymmetry beyond these cutoffs significantly raises the odds enough to justify imaging.
MRI: The Definitive Diagnostic Tool
Contrast-enhanced MRI is the gold standard for diagnosing acoustic neuromas. The scan uses gadolinium, an injectable contrast agent that makes tumors light up brightly against surrounding tissue. Well-performed MRI can reveal growths as small as 1 to 2 millimeters in diameter, making it exceptionally reliable for catching tumors early.
The gadolinium contrast is a critical part of the process. Non-enhanced MRI can miss small tumors entirely. There are faster, cheaper MRI techniques that skip the contrast dye, but these highly focused scans carry a tradeoff: they may miss other important causes of one-sided hearing loss, including other types of brain tumors, strokes, or demyelinating conditions like multiple sclerosis. A full contrast-enhanced scan catches a wider range of possible diagnoses.
If you have a metallic implant (such as certain older pacemakers or metal clips), MRI may not be safe for you. In those cases, a CT scan with contrast can substitute, though it’s less sensitive. CT reliably detects medium and large tumors but cannot be counted on to find anything smaller than about 1 to 1.5 centimeters.
Brainstem Response Testing
The auditory brainstem response (ABR) test measures electrical signals traveling from your ear to your brain. Small electrodes are placed on your scalp, and you listen to clicking sounds through earphones. The test tracks how quickly and completely nerve signals move along the hearing pathway, and a tumor pressing on the nerve will slow or distort that signal.
A large meta-analysis found that ABR detects acoustic neuromas with an overall sensitivity of about 93%. For tumors larger than 1 centimeter, sensitivity climbs to nearly 96%. But for smaller tumors under 1 centimeter, sensitivity drops to around 86%, meaning roughly one in seven small tumors gets missed. Its specificity sits at about 82%, so false positives are not uncommon. Because MRI outperforms ABR at catching small, early-stage tumors, ABR has largely shifted from a primary diagnostic tool to a supplementary one. It’s still useful in situations where MRI isn’t available or isn’t an option for a particular patient.
When NF2 Changes the Picture
Most acoustic neuromas occur spontaneously and affect only one ear. But when these tumors develop on both sides, the diagnosis points to a genetic condition previously known as neurofibromatosis type 2 (NF2), now being reclassified under updated international nomenclature to better distinguish it from neurofibromatosis type 1, which is a very different disease.
Diagnosis of this genetic form relies on a combination of clinical features and genetic testing. Bilateral acoustic neuromas in a young person are the hallmark finding, but doctors also look for other nerve tumors and characteristic eye or skin changes. Genetic testing can identify the specific mutations involved, which helps confirm the diagnosis and differentiate it from related conditions. If you’re diagnosed with an acoustic neuroma before age 30, or if you have a family history of these tumors, genetic evaluation is typically part of the workup.
What the Diagnostic Timeline Looks Like
Acoustic neuromas grow slowly, typically just 1 to 2 millimeters per year. This means symptoms often creep in so gradually that people adapt without realizing something is wrong. Many patients attribute their hearing changes to aging or earwax, and it’s not unusual for months or even years to pass between the first subtle symptom and a definitive diagnosis.
The typical path looks something like this: you notice hearing changes or persistent ringing in one ear, visit your primary care doctor, get referred for a hearing test, and if the audiogram shows significant asymmetry, get sent for an MRI. The MRI itself takes about 30 to 45 minutes. Results are usually available within a few days, and if a tumor is found, the next step is a referral to a specialist (typically a neurotologist or neurosurgeon) to discuss monitoring or treatment based on the tumor’s size and your symptoms.
Over 95% of patients with acoustic neuromas have measurable hearing loss by the time they’re diagnosed, even if they didn’t initially notice it. Catching the tumor earlier generally preserves more options, particularly for hearing conservation. That’s why any unexplained one-sided hearing change or persistent one-sided tinnitus is worth getting checked promptly rather than waiting to see if it resolves.